We validated the deficient cleavage process and the loss of protease function in this mutant form of HPN in our previous publication (Hsu et al
We believe that each patient is unique, so your individualized treatment plan will cater to what works best for you
In one study, 13.8% of individuals did not achieve a clinically-relevant weight loss, greater than or equal to, 5% at 68 weeks.1 In another, 17.8% were labeled non-responders.2 Though, why dont medications work for some people
A head-to-head clinical trial of injectable tirzepatide versus injectable semaglutide has already demonstrated superior weight loss with tirzepatide 12
By expanding access to FDA-approved obesity medications for Medicaid enrollees, TennCares actions clearly signal that we believe people living with obesity deserve evidence-based care, not judgment or denial
De La Vega Eterna M.D., founded in 2006 by Drs